Kevin Richardson

New Capabilities

As of September 2026: Leading the division that won FDA approval for Pixclara

Brain cancer doctors face a maddening problem: after radiation and chemo, standard MRI scans often can't tell whether a suspicious spot is tumor regrowth or treatment-related change. The two scenarios call for opposite treatments. The FDA just approved a test that settles the question.

Updated Sep 15